| scholarly article | Q13442814 |
| P50 | author | Jelena M. Janjic | Q55914353 |
| P2093 | author name string | Lu Liu | |
| Jonathan Williams | |||
| Christina Bagia | |||
| Jane E Cavanaugh | |||
| Michele Herneisey | |||
| Janja Mirtic | |||
| Sneha Potdar | |||
| P2860 | cites work | Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and ¹⁹F magnetic resonance | Q27317567 |
| 19F magnetic resonance imaging of perfluorocarbons for the evaluation of response to antibiotic therapy in a Staphylococcus aureus infection model | Q27318705 | ||
| Controlling molecular transport in minimal emulsions | Q27334998 | ||
| Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol | Q28343253 | ||
| Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells | Q28483244 | ||
| Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study | Q28486071 | ||
| Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
| Role of formulation vehicles in taxane pharmacology | Q33182080 | ||
| Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties | Q33760320 | ||
| Intracellular pH measurements using perfluorocarbon nanoemulsions | Q34399286 | ||
| Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces | Q34545939 | ||
| Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. | Q34617755 | ||
| Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. | Q34785236 | ||
| Resveratrol activates AMPK and suppresses LPS-induced NF-κB-dependent COX-2 activation in RAW 264.7 macrophage cells | Q35374759 | ||
| In vivo optical imaging and dynamic contrast methods for biomedical research | Q35687957 | ||
| Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health | Q35933890 | ||
| Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. | Q36011343 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. | Q36335331 | ||
| A novel probe for the non-invasive detection of tumor-associated inflammation | Q36694915 | ||
| Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions. | Q37064676 | ||
| Fluorine-containing nanoemulsions for MRI cell tracking | Q37634311 | ||
| Clinical trials of resveratrol | Q37831946 | ||
| Protein-surfactant interactions: a tale of many states | Q37852411 | ||
| Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries | Q37945775 | ||
| 19F magnetic resonance imaging of endogenous macrophages in inflammation | Q37987090 | ||
| Resveratrol: potential as anticancer agent | Q37995317 | ||
| Nanotheranostics for personalized medicine | Q38021283 | ||
| Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression? | Q38081415 | ||
| The First Scale-Up Production of Theranostic Nanoemulsions | Q38970529 | ||
| Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection | Q40014348 | ||
| Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems | Q45824631 | ||
| Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death | Q46287786 | ||
| Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress | Q48457738 | ||
| In vivo imaging platform for tracking immunotherapeutic cells | Q48947936 | ||
| Evaluation of the Stability and Antioxidant Activity of Nanoencapsulated Resveratrol during in Vitro Digestion | Q59347720 | ||
| The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion | Q79385800 | ||
| Edible delivery systems for nutraceuticals: designing functional foods for improved health | Q84817053 | ||
| Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions | Q86840143 | ||
| Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies | Q87262413 | ||
| Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy | Q87320378 | ||
| Cationic versus anionic surfactant in tuning the structure and interaction of nanoparticle, protein, and surfactant complexes | Q87477044 | ||
| Nutraceutical delivery systems: resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification | Q87641646 | ||
| Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy | Q88032457 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 795-808 | |
| P577 | publication date | 2016-11-11 | |
| P1433 | published in | Therapeutic delivery | Q26842827 |
| P1476 | title | Development and characterization of resveratrol nanoemulsions carrying dual-imaging agents | |
| P478 | volume | 7 |
| Q92681450 | Recent Strategies in Resveratrol Delivery Systems | cites work | P2860 |
Search more.